This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.
On Wednesday, Argentina’s Minister of Productive Development, Matías Kulfas , presented a bill titled, “Regulatory framework for the development of the medical cannabis and hemp industry ,” within the framework of the Economic and Social Council. Yahoo Finance reports. ley cáñamo argentina. .”
The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?
This data helps Californians understand the work we have ahead of us in realizing the promises of cannabis legalization, including supporting access to a safe, legal, and equitable cannabis market across the state and combating the unregulated, illicit market”. The data tool can be found on the DCC website here: [link].
McDonell said research institutions are limited in their access to cannabis users by federal laws that could affect funding. McDonell said he was approached by the tribe to work with them following a presentation at an addiction conference. The clinic serves native and non-native patients, according to the news release.
The general population in states where cannabis is legal has very easy access to a wide array of high-potency cannabis products, including extremely high-potency cannabis concentrates which can exceed 90% THC, and we’ve been limited to studying the whole plant with under 10% THC.”. “It View original article.
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.
3 This is really something, interesting presenters, well worth the money, and i actually will learn something. Cannabis licensees, testing labs, and third-party system integrators are invited to attend a webinar on the new CCRS system that will soon replace much of the reporting currently accomplished through the Leaf Data System.
Prohibition Holdings Ltd (parent company of Prohibition Partners) today announces its 100% acquisition of Business of Cannabis to form the industry’s new leader in media and data as well as the largest B2B audience in cannabis.
Research from New Frontier Data estimates that around 3 million people grow their own cannabis at home in the United States. The research conducted by New Frontier Data went on to show that 65% of those who grow cannabis at home were in a relationship or married, and 46% had children under the age of 18. Will you be one of them?
Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. This position is responsible for enforcing state laws, rules and regulations through application review, inspection and data reports, and regulatory compliance and enforcement. Advance statutory and industry standards.
BRAMPTON, Ontario–(BUSINESS WIRE)–DATA Communications Management Corp. Richard Kellam, President and CEO of DCM, and James Lorimer, CFO, will present Q2 results followed by a live Q&A period. Instructions on how to access both the webcast and telephone call are available below. Mr. Richard Kellam. 905) 791-3151.
Presented March 2 2020 here is the English preeamble. We committed to share data and I will highlight a few early observations: Michelle Boudreau. As Members are aware, Canada continues to implement our strict regulatory framework for cannabis, as a domestic public health approach.
Whole Genome Data. When it comes to sequencing your cultivar’s genetics for IP purposes, the more data the better. With more data, you can better describe your cultivar and make it harder for anyone else to claim novelty. Sequencing data is only as good as the reference to which it is compared. Publish to the Blockchain.
So, between the vision and the way the University of Illinois set this up, presented a very unique opportunity which I saw perhaps as the best way to get some of these things accomplished.” These are the right ways that we want to make sure we are restricting or allowing access to it, and that industry is booming.
The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. From there, former researchers working for big pharma will dictate what products are available to patients, how treatments are accessed, and cost. Threat to Patient Access in Oregon. You can contact Brett Mulligan at ?
This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.
Patients can also access CBD products without a prescription through local pharmacies. Our data confirm that PD patients have a high interest in treatment with medicinal cannabis but lacked knowledge about how to take it and especially the differences between the two main cannabinoids, THC and CBD,” said Buhmann.
Data that’s been published on the subject have been contradictory. The population-based cohort study used data from the Ontario portion of the 2009-2010 and 2011-2012 Canada Community Health Survey (CCHS). Pros and cons of any cannabis-related topic should be made easily accessible in relation to a study’s findings.
3 This is really something, interesting presenters, well worth the money, and i actually will learn something. This free-to-access webinar will provide financial strategies, regulatory updates and unique market insights around the Midwest cannabis industry. Data-driven insights and consumer behavior. Location: Webinar.
Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. This position is responsible for enforcing state laws, rules and regulations through application review, inspection and data reports, and regulatory compliance and enforcement. Advance statutory and industry standards.
Translating complex policy ideas into talking points, emails, briefs, and other publicly accessible communications. Collaborating with County departments, community leaders and other agencies to obtain data, provide analysis and convey results that support the Supervisor’s policy agenda.
At this year’s CannaTech Tel Aviv we were completely blown away by the articulate presenters and innovative products being pitched. This revolutionary storage device maintains optimal conditions for cannabis freshness and potency, and makes monitoring, tracking, dispensing, and procuring medical cannabis accessible to everyday patients.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.
According to quarterly datapresented by the US Treasury Department, over 800 banks and credit unions have filed paperwork with the United States government to state their relations with cannabis businesses. This hurdle has historically prevented the big traditional banks in the country from investing in the industry.
RocketFuel’s payment solutions are a game-changer for the cannabis industry which has long been denied access to traditional banking facilities like opening businesses accounts and having access to credit/debit card facilities.
High Tide gains access to Daily High Club’s over 15,000 subscription box members who are ideal customers for High Tide to potentially launch cannabis subscription boxes in the event of U.S. 1 As of June 21st, 2021, based on analytics data provided by Alexa Internet, Inc. Traffic data provided by Google Analytics.
The researchers used obesity data in Washington State between 2002-2018 because it is one of the first states to have legalized recreational or adult-use cannabis. digestive problems such as heartburn or gallbladder disease, sleep apnea, osteoarthritis and are even at the risk of presenting with more severe covid-19 symptoms. .
As the cannabis and hemp industries continue to grow, investor and M&A activities have become key areas of interest, but finding relevant business and financial data has been challenging. Cannabiz Intelligence solves the problem by bringing all of the data together in one place. Data Collection. Deal Flow Analysis.
With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry.
This impressive group represents well-known leaders in the psychedelic and addiction fields and will help usher in a greater understanding of the science and data behind what we expect to be the most effective treatments for many mental health conditions ever available.”. Chris Ray , PhD : Interventional Pain Physician. About Delic Corp, Inc.
Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021. Net loss for the six months ended 30 June 2021 was $30.2 million, or $0.79 million) compared with $24.8 million, or $2.61
“RocketFuel’s payment solutions are a game-changer for the cannabis industry which has long been denied access to traditional banking facilities like opening businesses accounts and having access to credit/debit card facilities. Tweet this.
Building the bridge between brands and the marketplace through testing and the importance of good data. A need for data at all of these levels and data specific to product type drives more advanced methodology in the laboratories, often resulting in a better understanding of the matrix and more accurate data.
Mack will present an overview of Virpax and take part in a fireside chat moderated by Noble Capital Markets senior equity research analyst, Gregory Aurand at the Pain Management Virtual Investor Forum on Thursday, October 7, 2021 at 9:00 a.m. Eastern time. www.youtube.com/channelchek. About Virpax Pharmaceuticals. Channelchek (.com)
Advertising That Is Tailored To Specific Demographics And Customers The utilization of data-driven marketing and analytics as a means of advertising that is tailored to specific demographics and customers has become an increasingly vital component of the cannabis sector.
BRAMPTON, Ontario–(BUSINESS WIRE)–DATA Communications Management Corp. Eastern Time) with a video webcast of the formal annual meeting, followed by a presentation from Richard Kellam, President and Chief Executive Officer of DCM, and a Q&A session. ABOUT DATA COMMUNICATIONS MANAGEMENT CORP. Mr. Richard Kellam.
In addition, “the agents did not report any strange transfer” or “any scale or excessive sums of money” “There is no objective data that points to the retail sale of drugs in that same place, not involving a considerable amount but quite the opposite,” adds the judge.
Individuals like Coltyn Turner, Alexis Bortell, and the late Charlotte Figi helped show America the power of cannabis and cannabinoid therapies, and thanks to the access we have to information today, their stories reached the masses. Medicinal cannabinoid therapies are saving and changing lives for people across America and around the world.
We compiled quantitative data to better understand barriers to entry and sustainability in legal cannabis markets,” Amber Littlejohn, Executive Director of the MCBA, told The Cannigma. “We Equitable industry: promotes the inclusion of minorities through equal access to opportunities and resources. The MCBA findings: a summary.
1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country. Replay Information.
.” 1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.
Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. Similar frameworks exist across the world, presenting the same set of challenges Canada has faced along the way. Shedding Stigma and Promoting Patient Access.
Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using. Sometimes the next-most abundant compounds can present a rich variability or even be more chemically active.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content